Adopting Quality Criteria for Websites Providing Medical Information About Rare Diseases by Pauer, Frederic et al.
Original Paper
Adopting Quality Criteria for Websites Providing Medical
Information About Rare Diseases
Frédéric Pauer1, MSc; Jens Göbel2, BSc; Holger Storf2, PhD; Svenja Litzkendorf1, MA; Ana Babac1, MSc; Martin
Frank3, PhD; Verena Lührs3, MA; Franziska Schauer4, Dr med; Jörg Schmidtke5, Dr med; Lisa Biehl6, Dipl Psych;
Thomas OF Wagner7, Dr med; Frank Ückert8, PhD; Johann-Matthias Graf von der Schulenburg1, PhD; Tobias Hartz3,
Dipl-Math
1Center for Health Economics Research Hannover (CHERH), Leibniz University Hannover, Hannover, Germany
2Medical Informatics Group (MIG), University Hospital Frankfurt, Frankfurt am Main, Germany
3Centre for Quality and Management in Healthcare, Medical Association of Lower Saxony, Hannover, Germany
4Department of Dermatology, Medical Center University of Freiburg, Freiburg im Breisgau, Germany
5Orphanet Deutschland, Center for Rare Diseases, Hannover Medical School (MHH), Hannover, Germany
6German Alliance of Chronic Rare Diseases (ACHSE) e.V., Berlin, Germany
7Frankfurt Center for Rare Diseases (FRZSE), University Hospital Frankfurt, Frankfurt am Main, Germany
8Department of Medical Informatics for Translational Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany
Corresponding Author:
Frédéric Pauer, MSc
Center for Health Economics Research Hannover (CHERH)
Leibniz University Hannover
Otto-Brenner-Str 1
Hannover, 30159
Germany
Phone: 49 511 762 14244
Fax: 49 511 762 5081
Email: frp@cherh.de
Abstract
Background: The European Union considers diseases to be rare when they affect less than 5 in 10,000 people. It is estimated
that there are between 5000 and 8000 different rare diseases. Consistent with this diversity, the quality of information available
on the Web varies considerably. Thus, quality criteria for websites about rare diseases are needed.
Objective: The objective of this study was to generate a catalog of quality criteria suitable for rare diseases.
Methods: First, relevant certificates and quality recommendations for health information websites were identified through a
comprehensive Web search. Second, all considered quality criteria of each certification program and catalog were examined,
extracted into an overview table, and analyzed by thematic content. Finally, an interdisciplinary expert group verified the relevant
quality criteria.
Results: We identified 9 quality certificates and criteria catalogs for health information websites with 304 single criteria items.
Through this, we aggregated 163 various quality criteria, each assigned to one of the following categories: thematic, technical,
service, content, and legal. Finally, a consensus about 13 quality criteria for websites offering medical information on rare diseases
was determined. Of these categories, 4 (data protection concept, imprint, creation and updating date, and possibility to contact
the website provider) were identified as being the most important for publishing medical information about rare diseases.
Conclusions: The large number of different quality criteria appearing within a relatively small number of criteria catalogs shows
that the opinion of what is important in the quality of health information differs. In addition, to define useful quality criteria for
websites about rare diseases, which are an essential source of information for many patients, a trade-off is necessary between the
high standard of quality criteria for health information websites in general and the limited provision of information about some
rare diseases. Finally, transparently presented quality assessments can help people to find reliable information and to assess its
quality.
(Interact J Med Res 2016;5(3):e24)   doi:10.2196/ijmr.5822
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Introduction
The European Union considers diseases to be rare when they
affect no more than 5 in 10,000 people. It is estimated that there
are between 5000 and 8000 different rare diseases, affecting
nearly 30 million people in the European Union and 4 million
people in Germany alone [1,2]. Consistent with this diversity,
the quality of information available on the Web varies
considerably. People searching the Web often find it very
difficult to find the right information and to assess its quality
[3,4]. With Orphanet [5], an information platform exists, which
holds comprehensive and quality-tested information. However,
the target group it addresses is potentially specialists rather than
patients [6,7]. In keeping with the European Council’s
recommendations, Germany has published a National Action
Plan for Rare Diseases in August 2013, which will guide and
structure actions in the context of rare diseases within their
health and social systems [8]. It includes 52 policy proposals.
The national project ZIPSE (German: Zentrales
Informationsportal über seltene Erkrankungen; English: Central
Information Portal about Rare Diseases), initiated by the Federal
Ministry of Health, deals with the realization of the plan’s topics
37 to 39, which cover the subject of a central information portal
[9]. Hereby, the health and well-being of people with rare
diseases should be improved.
The aim of the ZIPSE project is to conceptualize and implement
a central information portal about rare diseases in Germany. A
centralized access point for quality-tested information appears
to be very helpful for people with a rare disease, their relatives,
and medical experts [9]. The portal itself does not contain
primary information but refers to existing quality-assured
information sources. The aim is the provision of an intelligent
user guide to relevant and appropriate sources of information
[10]. Web-based information and websites about rare diseases
will be linked in the information portal. More precisely, a variety
of quality-tested websites about rare diseases will be offered to
all users. Furthermore, users will be able to search for
disease-specific websites and to filter them by quality criteria.
Therefore, a method to distinguish high- and low-quality
websites needs to be established [10,11]. A number of quality
certificates for websites dealing with medical information
already exist. Websites with such a certificate demonstrate
quality-tested content [3]. It can be hypothesized that existing
quality certificates for websites with health information (eg,
Health On the Net Foundation Code of Conduct, HONcode;
DISCERN; and Stiftung Gesundheit) are rarely used by websites
about rare diseases. It can be assumed that patient organizations
often provide well-researched and reliable information about
rare diseases, but they have limited resources in terms of time
and money to present themselves as professionally as other
information providers on the Web to fulfill the requirements of
existing quality certificates. Furthermore, the providers’
motivation to present themselves professionally is unknown.
The quality control process of certificates such as HONcode
can be costly and require significant effort owing to stringent
requirements. Verifying websites providing medical information
about rare diseases using quality criteria can help increase
acceptance and signal trustworthiness to patients, relatives, and
medical experts. Most existing quality certificates focused on
medical information pursue different goals and contain a wide
range of different types of quality criteria. Hence, specific
quality criteria for websites about rare diseases are needed. The
objective of this study was to generate a catalog of quality
criteria suitable for rare diseases. Implementing these quality
criteria will improve the evaluation and assessment of
information about rare diseases for patients, health professionals,
and other users of the information portal.
Methods
The method we adopted can be regarded as a process divided
into 3 steps, as shown in the flowchart in Figure 1.
In step 1, a comprehensive Web search was performed to
identify quality certificates and criteria catalogs for websites
containing medical or health information. Although we focused
on programs and catalogs active in Germany because of its
implementation of the information portal about rare diseases,
we considered several international sources as well. Quality
certificates and criteria catalogs were only included if the quality
criteria were published transparently. Furthermore, to be
included the certificates and catalogs had to focus on Web-based
resources containing medical or health information. Certificates,
catalogs, and recommendations were therefore excluded if, for
example, they focused only on printed medical information.
Additionally, websites about rare diseases were analyzed to
identify their quality criteria and their use of quality certificates.
These criteria were added if they were not already identified
through the Web search. Finally, all identified references were
again checked for suitability.
In step 2, the unique criteria of each certification program and
catalog were examined, extracted into an overview table, and
analyzed by thematic content. Thematic correlations between
the criteria were pooled together with an inductive design into
major categories. Experts on rare diseases were consulted on
the construction of the major categories. Finally, each criterion
was assigned to one of the following major categories: thematic,
technical, service, content, and legal. Where feasible, the
categories were broken down further into groups of criteria.
Additionally, experts on rare diseases provided opinions and
general information about the importance of each criterion and
critical aspects of quality criteria for information about rare
diseases. If a criterion was already present in the map, it was
not reentered but marked as being part of another criteria
catalog. In order to evaluate the importance of a single criterion,
its repeated occurrence among different criteria catalogs was
examined. Criteria appearing in several catalogs were considered
more important, whereas those that were part of a single catalog
alone were considered less important. Thus, a hierarchy of the
quality criteria appearing in the identified catalogs was
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constructed, ordered from the criteria appearing the most number
of times to those appearing just once.
In step 3, the most important criteria were selected by the project
group as preliminary quality criteria. Next, a workshop was
held with various experts on website quality and other
publications with medical content, experts on health economics
and medical informatics, as well as medical experts in the field
of rare diseases. A total of 27 experts participated in the
workshop—4 of them were professors and 12 graduate doctors.
These experts were invited to participate in the group discussion
about quality criteria for websites providing medical information
about rare diseases. Participants did not receive incentives to
attend the workshop and discussion. The relevance and
applicability of each quality criterion were discussed, evaluated,
and verified by the expert group. The discussion with medical
experts as well as experts on the quality of medical information
focused on choosing the criteria that should be mandatory for
websites offering medical information on rare diseases. Input
from medical experts was equally valuable as input from experts
on quality of medical information. At the end of the discussion,
the experts were expected to arrive at a consensus on the
importance of the different quality criteria. Finally, it was
decided which of the quality criteria should be mandatory for
these websites to be listed on the information portal about rare
diseases. Experts from the following institutions participated
in the workshop and group discussion:
• German Action Forum Health Information System (afgis
e.V.)
• German Alliance of Chronic Rare Diseases (ACHSE e.V.)
• Agency for Quality in Medicine (ÄZQ)
• Federal Ministry of Health Germany (BMG)
• Charité Universitätsmedizin Berlin
• Center for Health Economics Research Hannover (CHERH)
• German Cochrane Center (DCZ)
• Frankfurt Reference Center for Rare Diseases (FRZSE)
• Institute of Medical Biostatistics, Epidemiology and
Informatics (IMBEI), University Medical Center Mainz
• Institute for Quality and Efficiency in Health Care (IQWiG)
• Cancer Information Service Heidelberg (KID)
• Hannover Medical School (MHH)
• National Action League for People with Rare Diseases
(NAMSE)
• Orphanet Germany
• Public Health Foundation
• Department of Dermatology, Medical Center University of
Freiburg
• University Medical Center Hamburg-Eppendorf (UKE)
• Centre for Quality and Management in Healthcare, Medical
Association of Lower Saxony (ZQ)
Figure 1. The three steps of the analyzing procedure.
Results
Identification of Relevant Certificates
A total of 9 quality certificates and criteria catalogs for websites
containing medical or health information were identified. Of
these certificates and catalogs, 2 were used internationally; 7
were verified only for German websites. The most common
certificate for medical information websites was identified as
HONcode [12]. Three further certificates verifying only German
websites were identified: afgis Qualitätslogo [13], Stiftung
Gesundheit [14], and Medisuch [15]. Additionally, several
German, European, and international criteria catalogs were
considered: afgis Checkliste für medizinische Websites [16],
DISCERN [17], Gute Praxis Gesundheitsinformation [18],
NAMSE Kriterien und Standards [19], and Patientenorientierte
Krankheitsbeschreibung nach ACHSE-Kriterien [20]. Lastly,
the results of a study identifying the most important quality
criteria for medical information websites were analyzed [21].
All identified quality catalogs are described in Table 1.
Furthermore, the development of quality criteria is an ongoing
process, including more detailed quality assurance whereby
recent quality catalogs take into account older catalogs and
quality certificates. In summary, the identified quality catalogs,
certificates, and recommendations show different thematic
focuses on the criteria that are considered important to ensure
a high quality of health information. Moreover, Table 1 shows
that the process of determining the quality of information differs
among the identified providers (self-reporting audits vs publicly
available information).
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Table 1. Quality catalogs and quality certificates.
Number of
criteria
(n=304)
CharacteristicsDescriptionName
56It contains requirements for the categories:
creation process,
results,
implementation, and
evaluation.
A discussion paper about quality criteria for
enhancing patient information about rare
diseases.
NAMSE Kriterien und Standardsa
[19]
55Its principles:
Information must be authoritative—stating the
qualifications of the author.
Complementarity—information must supplement
and help to support medical advice, not replace it.
Privacy—compliance with confidentiality of person-
al data entered by a website visitor.
Assignment—References to sources of information
and dates must be present.
Verifiability—treatments, products, and services
must be supported by balanced, verifiable, scientific
information.
Transparency and contact information.
Disclosure of funding—sponsorship, sponsors, and
financial sources must be named.
Advertising policy—separation of advertising and
editorial content.
As an international certificate, awarded by
the Health On the Net Foundation located
in Switzerland and established in 1995, it
has held NGOc status at the United Nations
since 2002. Since 1996, a free certificate
for “trusted” sites with medical information
was awarded. Since 2015, certification is
provided as a paid service. The organization
claims that about 8000 medical websites
hold their certificate.
HONcodeb [12]
39It is based on 10 quality categories for transparently
provided information:
criteria for transparent information about providers,
purpose and target group,
authors and information sources,
data release, timeliness, and planned maintenance
of the information,
possibility to give user-feedback,
procedure of internal quality assurance,
separation of advertisement and editorial contribu-
tion,
financing and sponsoring,
cooperation and networking, and
data protection, data transmission, and use of data.
The afgis Qualitätslogo is based on 10
quality categories for transparently provided
information, whereby the verification is
based on self-reporting audits.
afgis-Qualitätslogod [13]
35It contains essential Web standards for the following
categories:
timeliness,
data protection,
design and navigation,
medical information,
legal aspects,
service aspects,
search engine,
transparency, and
access.
afgis Checkliste für medizinische Websitese
is a guideline for providers that want to re-
generate websites with medical information
content.
afgis Qualitätskriterien [16]
30It focuses on the development of health information
with a requirement for evidence-based information,
A catalog containing quality criteria for the
development of health information with a
requirement for evidence-based information.
Gute Praxis Gesundheitsinformationf
[18]
which is comprehensible given the expertise of the
target group. Thus, the catalog contains different
criteria for various target groups.
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Number of
criteria
(n=304)
CharacteristicsDescriptionName
30It awards a seal of approval after checking criteria
out of the following categories:
legal quality,
publishing diligence,
usability, and
search engine optimization.
Awards a seal of approval after checking
more than 100 issues, whereby the verifica-
tion is based on information that is available
on the website.
Stiftung Gesundheitg [14]
28It contains quality criteria of the following cate-
gories:
creation and formal aspects,
medical-scientific data and information,
disease management,
establishment of contact and information about
specialties of health professionals, and
additional links and references.
Contains quality criteria grouped into 5
categories.
Patientenorientierte Krankheits-
beschreibung nach ACHSE-Krite-
rienh[20]
19It focuses on the following:
reliability of the publication and
quality of information on treatment alternatives.
A tool to evaluate medical publications with
a focus on patient information.
DISCERN [17]
12As a part of its certification process, information
providers have to declare that the information pro-
vided on the website is not influenced by industrial
offers.
Provides a certification process and is oper-
ated by the institute for quality and trans-
parency of health information.
Medisuch [15]
a NAMSE Kriterien und Standards: NAMSE (National Action League for People with Rare Diseases) criteria and standards (in English).
b HONcode: Health On the Net Foundation Code of Conduct.
c NGO: nongovernmental organization.
d afgis Qualitätslogo: German Action Forum Health Information System (afgis) quality logo (in English).
e afgis Checkliste für medizinische Websites: afgis checklist for medical websites (in English).
f Gute Praxis Gesundheitsinformation: good practice health information (in English).
g Stiftung Gesundheit: Public Health Foundation (in English).
h Patientenorientierte Krankheitsbeschreibung nach ACHSE-Kriterien: patient-oriented description of disease by the criteria of ACHSE (German Alliance
of Chronic Rare Diseases) (in English).
Analysis and Extraction of Quality Criteria
The number of criteria present in the quality certificates is listed
in Table 1. The presented number can be higher (or lower) than
the official numbers stated by the providers owing to a more
detailed valuation of criteria by the project group. The number
of criteria ranged from 12 to 56 in the catalogs analyzed. In
total, we identified 304 single criteria items. Through this, we
aggregated 163 different quality criteria into 5 major categories:
thematic, technical, service, content, and legal. The thematic
criteria category containing 90 criteria (90/163, 55.2%) was by
far the largest, followed by the service category with 26 criteria
(26/163, 16.0%), the technical category with 18 (18/163, 11.0%),
the legal category with 15 (15/163, 9.2%), and the content
category with 14 (14/163, 8.6%). The degree of detail varied
among the different criteria catalogs, and while 66 criteria
(66/163, 40.5%) were found in multiple catalogs, no criterion
was found in all of the certificate definitions or criteria catalogs.
The 2 most frequently occurring criteria appeared in 6 of the
analyzed catalogs (6/9, 67%). Three criteria appeared in 5 (5/9,
56%) and 13 criteria in 4 of the catalogs (4/9, 44%), whereas
20 criteria appeared in 3 (3/9, 33%) and 28 criteria in 2 of the
catalogs (2/9, 22%). The majority of 87 criteria were unique to
a single catalog. With the exception of one catalog (Gute Praxis
Gesundheitsinformation), each contains a criterion unique to
itself. All identified quality criteria are presented in Multimedia
Appendix 1. In summary, the number of criteria present in
quality certificates and quality catalogs differs. Nevertheless,
most catalogs contain a unique criterion not shown elsewhere.
The number of quality criteria in each of the major categories
varies widely.
Expert Verification
To assess the relevance of a quality criterion specific to websites
offering medical information on rare diseases, different
principles were applied. First, criteria appearing in many of the
reviewed catalogs were considered more important to ensure a
certain level of information quality. This resulted in initially
selecting the two most abundant criteria (authors are mentioned
and creation and updating dates of information are mentioned)
as mandatory for websites to be listed in the information portal
ZIPSE. Criteria appearing less often were only selected in
consideration with their relevance and their applicability to rare
diseases and the targeted websites. This relevance was assessed
by checking several properties. If a criterion is applicable, it is
to a certain extent defined by its feasibility. Criteria seemingly
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important to the quality of general medical information may
only be adapted to a limited extent. Finally, in the discussion
workshop with 27 experts, quality criteria for websites offering
medical information on rare diseases were defined. A consensus
about the following 13 quality criteria for websites offering
medical information on rare diseases was determined:
• Authoring information
• Mentioning of authors
• Mentioning of sources
• Mentioning of creation and update date
• Data security
• Declaration of evidence
• Marking of conflicts of interests
• Consideration of target group
• Evaluation of content
• Review of information
• Characteristics of the website (accessibility)
• Imprint
• Contact opportunity
A decision was made on the quality criteria that should be a
mandatory requirement for websites about rare diseases for
them to be listed in the information portal. As a legal
requirement for all websites, an adequate data protection
concept as well as an imprint is mandatory. Moreover, we
identified the creation and updating date and the possibility to
contact the website provider as very important categories for
patients with a rare disease.
Discussion
Principal Findings
The literature review of quality catalogs, certificates, and
recommendations for websites containing medical or health
information showed different thematic focuses on criteria that
are important for the quality of health information. Interestingly,
the investigated certificates reveal a great variety of quality
criteria used by the common certificates. There is also a wide
range of quality criteria where the degree of detail varied among
the different criteria catalogs. Furthermore, the process for
determining the quality of websites differs among the identified
providers (self-reporting audits, eg, [13] vs publicly available
information, eg, [14]). The classification of the quality criteria
into the major categories, thematic, technical, service, content,
and legal, showed that the number of quality criteria in each
category varies widely. The presence of a larger number of
quality criteria in one category does not necessarily indicate a
greater relevance of the category. It is rather an indication that
this category can be investigated more thoroughly than
categories with a smaller number of different criteria [12].
Defined quality criteria for websites about rare diseases were
coordinated and verified by a multidisciplinary expert group to
ensure the quality of the information provided. These quality
criteria will be applied for registration of websites on the portal
about rare diseases. Out of the 13 verified quality criteria for
websites about rare diseases, 4 were identified to be mandatory
for registration to the information portal. First, as a legal
requirement for all websites an adequate data protection concept
and an imprint are mandatory. Moreover, creation and updating
date and possibility to contact the website provider were
identified as very important categories for patients with a rare
disease. The documentation of the creation and updating date
of information is especially important owing to rapid advances
in the development of information and to demonstrate the latest
research findings [22]. The possibility to contact the website
provider is also an important quality aspect for these websites.
Particularly, if there is limited information elsewhere, patients,
health professionals, and other users can offer the provider
advice or suggestions for improvement or ask for more precise
information about a rare disease [23]. These 4 categories are
mandatory for registration to the information portal and for
linking to medical information about rare diseases. Fulfillment
of the remaining 9 categories is optional. Nonetheless, these
categories are still important for quality-tested information about
rare diseases. To achieve transparency, it would be beneficial
to publish the degree to which the websites fulfill these
categories. In particular, information on the characteristics of
the website, such as its accessibility, is important for many
patients [24]. Thus, the fulfillment of each single low-barrier
criterion needs to be shown transparently.
Using quality criteria to verify websites providing medical
information about rare diseases can help to improve their
acceptance and signal trustworthiness to patients, relatives, and
medical experts [3]. In further studies, all selected quality criteria
will be transferred to a so-called self-disclosure questionnaire.
These questions will then be used to assess the quality of rare
disease websites. The results from the first evaluation of these
can help to improve and adjust the quality assessment process
of the information portal. Moreover, we can evaluate and test
the assumptions made at the beginning:
• Do patient organizations provide well-researched and
reliable information about rare diseases?
• Do they present themselves as professionally as other
information providers on the Web to fulfill the requirements
of existing quality certificates?
• Do websites with little content and a small editorial staff
hold high-quality information?
A further problem for investigation is the availability of robust
evidence of information on rare diseases. Providing evidence
for the source of information is a requirement often sought to
ensure a piece of information is well researched. However, with
merely 5 in 10,000 people affected by rare diseases, it is almost
impossible to collect sufficient data to statistically test a
hypothesis. It could be argued that a single proven case is also
a form of evidence, albeit a very thin one. However, as long as
no other data exist, it is still the best evidence available [25].
There are also important implications for future research from
analysis of those categories where we identified a lower number
of different criteria. New detailed quality criteria on these
categories may help improve the discussion on quality of
websites providing medical information.
Limitations
Despite our focus on programs and catalogs active in Germany,
we identified a large number and variety of different quality
criteria. As with other quality catalogs, the defined criteria
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cannot verify the thematic content of health information. These
criteria simply verify factors influencing the thematic content,
as well as the quality of the website itself. A more complex and
expensive solution to verify the heterogeneous information
about rare diseases would be for medical experts to verify and
highlight single articles of listed websites about rare diseases
in the information portal. The defined quality criteria for such
websites were verified by the participants of a workshop.
Although this workshop was held with 27 renowned and
excellent experts on website quality and other publications with
medical content, experts on health economics and medical
informatics, as well as medical experts in the field of rare
diseases, subjectivity in their decision-making process cannot
be ruled out.
Conclusions
The relatively low intersection of criteria appearing in the
different criteria catalogs shows that the opinion of what is
important concerning quality of medical information differs.
For the development of useful quality criteria for websites about
rare diseases, a trade-off between the high standard of quality
criteria for general health information and the provision of
limited existing information about rare diseases, which is
essential for many patients, appears unavoidable. Providing
defined quality criteria for websites about rare diseases can help
seekers to find reliable information and to assess its quality
[3,4]. Accepted criteria for websites with information about rare
diseases, which allow for a minimum of quality control while
keeping the workload reasonable, have been defined. In
summary, 13 categories with quality criteria were defined by a
group consisting of medical experts as well as experts on the
quality of medical information. Fulfillment of 4 of these
categories (data protection concept, imprint, creation and
updating date, and possibility to contact the website provider)
was identified as being mandatory for registration to the
information portal and for publishing medical information about
rare diseases. With the help of these quality criteria, we can
evaluate, for instance, the quality of information provided by
rare disease self-help groups or other information providers.
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